Reputation Audit — Miami Vitality & Aesthetics

This is the Reputation chapter of your full audit. It looks only at what the public says about you and how you respond to it — the chorus of voices on Google, the social channels, the healthcare-specific review sites, and the back-channels like Reddit where prospective patients quietly compare notes before they ever call. It does not grade your website, your AI-search visibility, or your compliance posture; those live in their own chapters. Where reputation and compliance touch — and for a clinic making aggressive health claims, they touch hard — we flag it and point you to the Compliance chapter.

Your overall reputation score is 50 out of 100. That is a middling number, and it is middling for an interesting reason: you are genuinely liked by the patients who walk out happy, and you have built real review volume, but you are leaving most of that goodwill unmanaged, unanswered, and uncaptured. A 4.4-star clinic with 260 reviews and a 12% response rate is a clinic that has earned a reputation and then walked away from the controls. The good news in that sentence is the same as the bad news: almost everything dragging this score down is within your direct control.

We score five sub-dimensions. Here they are at a glance, then we work through each in detail.

Reputation is not one number on one site; it is a distributed conversation, and different audiences land in different places. A 38-year-old Miami professional Googling "IV drip Brickell" sees one thing. A patient in Bogotá researching hormone therapy abroad finds you somewhere else entirely. Here is where your reputation actually lives.

Google Business Profile — your center of gravity

~260 reviews · 4.4★ · owner-response rate ~12%

Google is doing most of the heavy lifting for you, and it is the first and often only place a local prospect looks. The volume here is genuinely respectable — 260 reviews puts you well past the credibility threshold (most prospects start trusting an aggregate rating somewhere north of 30–40 reviews) and signals an established, busy practice. The 4.4 rating is good. It is not, however, the 4.7–4.9 that the best-run medspas in competitive metros now post, and in aesthetics the gap between 4.4 and 4.8 is the gap between "probably fine" and "obviously the one to book."

The concentration is the structural risk. With the overwhelming majority of your public reviews sitting on a single platform, your reputation has a single point of failure. If a cluster of unhappy patients lands in the same month, or if Google filters a batch of your reviews (it periodically does, often the enthusiastic ones), your headline number can move fast and you have no second platform absorbing the shock.

The response rate — roughly one reply for every eight reviews — is the headline failure of this whole audit chapter, and we return to it in Section 3.

Instagram & TikTok — high reach, low reputational capture

Your social presence is aggressive and well-resourced; the Marketing chapter credits it. But for reputation purposes, social is a leaky bucket. The comments under a before/after reel are real sentiment data — questions about pricing, "is this safe?", "does it actually last?", DMs asking what a given peptide "cures." Those interactions shape buying decisions every bit as much as a Google star, yet they vanish down the feed and are never consolidated into anything a future patient can find. Worse, social comment threads are where aggressive health-claim language tends to live most casually, which is a compliance exposure (see Section 5 and the Compliance chapter). Reputationally, treat social as a sentiment listening post you are currently not listening to.

Healthgrades & RateMDs — physician-level reputation

Because you are physician-led, the doctor's name carries its own reputation independent of the clinic brand. On the clinician-review platforms (Healthgrades, RateMDs, Vitals), composite practices like this one typically show thin, dated coverage — a handful of reviews, often years old, sometimes inherited from a prior practice. That thinness is a missed asset: these profiles rank well in search for "[Dr. Name] Miami reviews," they feed the E-E-A-T signals the GEO chapter cares about, and they reassure the more clinically-minded patient who wants to vet the physician, not just the spa. Right now this channel is essentially unmanaged.

RealSelf — the aesthetics-specific arena

For the Botox and dermal-filler side of the business, RealSelf is the category-defining platform, and it behaves differently from Google: patients post detailed treatment narratives, "Worth It" ratings, and cost discussions, and they actively compare providers. A modern, aggressively-marketed aesthetics practice with little or no RealSelf footprint is invisible in exactly the place its highest-intent cosmetic prospects do their research. This is a clear coverage gap rather than a problem — there is likely nothing negative here, just nothing at all.

Bookimed / PlacidWay — the medical-tourism layer

Your Latin-American medical-tourism segment researches through medical-tourism aggregators and Spanish-language channels that your domestic competitors largely ignore. Coverage here is almost certainly minimal today. That is both a gap and an opportunity: a credible, Spanish-language reputation presence aimed at the international patient is a moat very few Miami medspas bother to build.

Reddit & forums — the unfiltered back-channel

On Reddit (r/Miami, local beauty and biohacking subs) and similar forums, prospects ask each other the questions they won't ask you: "Is [clinic] legit or just upsell?" "Anyone actually do TRT there — worth the money?" This is where your "upsell-y" friction theme does the most quiet damage, because it gets repeated by strangers with no incentive to be kind. You cannot control these threads, but you can monitor them, and right now you almost certainly are not.

Yelp & BBB — secondary but not zero

Yelp matters less for cash-pay medical than for restaurants, but it still surfaces in search and its filter is aggressive. BBB matters mainly as a trust-checkpoint for the more cautious, often older hormone-optimization patient and for the international patient verifying you are a real business. Both are likely lightly populated; neither is urgent, but both should be claimed and minimally maintained.

Volume and stars tell you how many and how high. Sentiment tells you why, and the why is where the strategy lives. Reading across your review corpus, the emotional shape is clear: a warm, enthusiastic core of delighted patients, pulled down by two specific and recurring frictions. Your sentiment sub-score is 52 — net positive, but the frictions are doing real work against you.

What patients praise (and you should amplify)

Visible results. This is the strongest, most repeated theme, and it is the best possible kind of praise for an aesthetics and optimization practice. Patients describe looking better, feeling more energetic, seeing changes friends noticed. Results-driven praise converts prospects better than any other category because it speaks directly to the buying motive. Strategic note: this same praise is also your largest compliance liability, because results testimonials that imply typical or guaranteed outcomes — especially for hormone, peptide, and IV services — are exactly what the FTC scrutinizes. Amplify these reviews, but the way you amplify them (disclaimers, "results not typical," substantiation) is a Compliance-chapter question you must resolve before you lean into them in marketing.

Attentive, concierge-style service. Patients repeatedly describe feeling looked-after — remembered by name, unhurried, made to feel like a VIP. For a cash-pay clientele paying a premium, this is the experience they are actually buying, and it is a genuine differentiator. This theme is pure upside with no compliance tail. Lean into it hard.

Modern, beautiful facility. The space photographs well and patients mention it. It reinforces the premium positioning and the "this is a serious, well-run place" signal that reassures the international patient especially.

Where the friction lives (and what it's costing you)

Pricing — high, opaque, and perceived as "upsell-y." This is the dominant complaint theme, and it is corrosive in a specific way: it does not say you're bad, it says you can't be trusted on money. The pattern in the reviews and back-channels is consistent — patients feel quoted one thing and sold another, pushed toward add-ons, surprised at checkout. In a cash-pay model where every dollar is felt, this theme directly suppresses both your star rating and your word-of-mouth, and it is the exact thing strangers repeat on Reddit. It is also, notably, not a quality complaint — these are often patients who liked their results. They liked the outcome and resented the sell. That distinction is the whole opportunity: this is fixable with transparency, not with better medicine.

Inconsistent results messaging. A subtler but important theme: some patients arrive expecting outcomes they didn't get, or describe results that "didn't last like they said." This is a promise-calibration problem rooted in your aggressive marketing — the louder the claim up front, the larger the gap a normal-variance result can fall into, and the more likely a satisfied-enough patient writes a lukewarm or disappointed review. This friction sits at the exact intersection of reputation, marketing, and compliance: dialing the claims to what you can reliably deliver would simultaneously lift sentiment, reduce review disappointment, and shrink your FDA/FTC exposure. One change, three wins.

Emotional intensity & specificity

Your positive reviews tend to be specific and warm ("Dr. ___ and the team," named staff, described results) — high-credibility, high-conversion reviews. Your negative reviews tend to be specific too, and specificity cuts both ways: a detailed "here's how the upsell went" review is far more damaging than a vague one-star, because prospects believe it. There is no significant pattern suggesting fake or AI-generated reviews in either direction, which is good — your reputation is real, earned, and therefore movable by real operational change.

This is the lowest sub-score in the chapter — 35 — and it is the single highest-leverage fix in the entire reputation picture.

You respond to roughly 12% of your reviews. Put plainly: for every eight patients who took the time to write about you in public, seven hear nothing back. That silence is not neutral. It is read by every future prospect scrolling your profile, and it sends three damaging signals at once.

• First, it signals you're not listening — to everyone. A prospect doesn't just read the reviews; they read you reading the reviews. A profile where the owner thanks happy patients and thoughtfully addresses unhappy ones reads as an engaged, accountable practice. A profile of unanswered reviews — even glowing ones — reads as a busy place that has stopped paying attention. For a premium concierge brand, that is directly off-message.
• Second, unanswered negative reviews are a standing invitation to believe the worst. When a patient writes "felt pressured into add-ons I didn't need" and there is no reply, the complaint stands as the uncontested last word. A calibrated, non-defensive owner response — acknowledging the experience, restating your pricing transparency, offering to talk offline — doesn't just repair that one relationship; it reassures the next fifty readers that you take the concern seriously. Your dominant friction (pricing/upsell) is precisely the theme that most needs visible, consistent owner responses, and it is going almost entirely unaddressed.
• Third, you're forfeiting a known ranking and conversion benefit. Responding to reviews is associated with stronger local-search performance and measurably higher prospect trust. We never promise rankings, and response management is not a magic lever — but consistently engaging reviews is one of the better-evidenced, lower-cost reputation practices available, and you are largely skipping it.

A critical compliance caveat on responses. Because you are a healthcare provider, your review responses are bound by HIPAA. You may not confirm, deny, or reference any individual's status as a patient or any clinical detail in a public reply — even to defend yourself, even if the reviewer disclosed it first. Many practices commit casual HIPAA violations precisely in their review responses ("We're so glad your hormone levels improved, Maria!"). The fix is a templated, HIPAA-safe response framework that never acknowledges treatment specifics and always moves clinical conversation to a private channel. Drafting that framework and a set of ready-to-paste responses is handled in the separate owner-response file; this chapter only diagnoses the gap.

The opportunity, sized. Moving from ~12% to a sustained 90%+ response rate — every review answered within 48 hours, every negative one within 24 — is the kind of change that lifts the visible character of your profile within a single quarter. It costs staff time and a good template, nothing more.

Reputation is graded on a curve, and the curve is your local market. A 4.4 in a town of 4.0 clinics is a winner; the same 4.4 against a field of 4.8s is a quiet loser. Below we benchmark you against three invented, illustrative-composite competitors representing the realistic shape of the Miami medspa/longevity field. (These are fictional composites created to illustrate competitive dynamics, not real businesses.)

What this table says.

You are mid-pack, and the leader beats you on exactly your weak spots. "Brickell Glow" (composite) is the cautionary benchmark: more reviews, a noticeably higher rating, and — tellingly — an 85% response rate. They are not necessarily better clinicians; they are better reputation operators. Their higher star average is partly a consequence of disciplined response management and a public reputation for transparent, no-surprise pricing — the precise friction that drags you down. They have turned your weakness into their positioning.

"Coral Peak" (composite) shows the authority play. Smaller in volume but higher-rated, with physician-led content and carefully calibrated claims. They demonstrate that you do not need the most reviews to win the trust-sensitive patient — you need the cleanest signal. Their measured claims also give them a lower crisis-vulnerability profile than yours.

"Aventura Aesthetic MD" (composite) is your mirror. Similar aggressive marketing, similar "upsell-y" friction, similar thin response rate. They are the version of the market you are currently competing as. The strategic question is whether you want to keep racing Aventura to the bottom on pricing-perception, or break toward the Brickell Glow / Coral Peak model of transparency and engagement, which commands higher ratings and higher trust at the premium price point you already charge.

The competitive gap, in one sentence: your rivals who win are not out-marketing you — you out-market most of them — they are out-managing their reputation, especially on responses and pricing transparency. That is a gap you can close without spending another dollar on ads.

This sub-score is inverted — a higher number means more exposure — and yours sits at 50, meaning elevated vulnerability. The driver is not your patients; it is your claims.

Aggressive health claims are your fault line. A medspa that markets hormone optimization, peptides, and IV therapy with strong outcome language ("reverse," "cure," "boost immunity," "anti-aging," disease-adjacent benefits) is carrying a category of risk that a Botox-and-facials spa simply isn't. The reputational crisis scenarios that follow from aggressive claims are specific and foreseeable:

• A regulatory action becomes a reputation event. An FDA warning letter or FTC inquiry over deceptive health claims is, by design, public — and in the social-media age it is screenshot, shared, and permanent. The Compliance chapter scores this exposure at its true severity (Compliance is your lowest dimension, 25/100). For reputation purposes, understand that your claims are not only a legal liability; they are a latent reputation bomb with a public fuse.
• A disappointed-outcome review escalates. When marketing promises big and a normal-variance result disappoints, the gap can produce not just a one-star review but a "they promised X and it didn't happen" narrative that other prospects — and occasionally journalists or regulators — find compelling. Your "inconsistent results messaging" friction is the early-warning signal that this dynamic is already live.
• An adverse-event or safety question goes public. Injectables and infusions carry inherent clinical risk. A single adverse-event review, especially if met with a defensive or HIPAA-careless response, can dominate your profile. You have no published crisis-response protocol, no monitoring, and a 12% response rate — meaning today you would likely learn about such an event late and respond badly.

Why your defenses are thin right now. Three things compound the exposure: (1) low response rate means slow detection and reaction; (2) single-platform concentration means one bad cluster moves your headline number fast; (3) aggressive, loosely-calibrated claims maximize the gap a complaint can exploit. None of these are exotic — they are the standard ingredients of medspa reputation crises, and you have all three.

The reframe: lowering crisis vulnerability does not require softening your brand into beige. It requires (a) calibrating claims to what you can substantiate — which is also the Compliance fix — (b) installing monitoring so you hear bad news first, and (c) having a HIPAA-safe response protocol ready before you need it. Done together, these would move this sub-score meaningfully toward "well-defended."

Here is a quiet inefficiency: you almost certainly serve far more happy patients than ever write a review. A busy cash-pay medspa sees hundreds of patient visits a month; 260 lifetime reviews suggests you are capturing a small fraction of your goodwill in public. Every delighted patient who walks out and doesn't leave a review is reputation you earned and didn't bank.

This gap is why your two-pronged opportunity is so attractive. You don't need to manufacture sentiment — your patients already feel it. You need a systematic, compliant ask that converts existing satisfaction into public proof, biased toward the platforms where it matters most (Google first, then RealSelf for aesthetics, then Healthgrades for the physician, then Spanish-language channels for the international patient).

A disciplined review-generation program at your visit volume can realistically add a steady stream of new, recent, specific reviews — and recency matters as much as count, because prospects discount old reviews and Google weights fresh ones. A rising tide of genuine 5-star reviews also does something quietly powerful: it dilutes the influence of any single negative, lifting your average toward the 4.7+ band where booking decisions tip.

One firm guardrail: review generation in healthcare must be compliant. You may ask every patient and make it easy; you may not offer incentives in exchange for reviews (an FTC problem), may not gate or suppress negative reviews ("review-gating" is an FTC deceptive-practice concern and violates platform rules), and must keep every ask HIPAA-respectful. The right program asks everyone and simply makes the satisfied majority's voice easier to hear. The plan below is built that way.

Ordered by leverage. The first three are near-free and high-impact; treat them as the quarter's priorities.

Priority 1 — Close the response gap (weeks 1–4)

• Commit to a 90%+ response rate: every review answered within 48 hours, every negative within 24.
• Adopt a HIPAA-safe response framework (no patient-status confirmation, no clinical detail, always move specifics to a private channel). Ready-to-use drafts are in the separate owner-response file.
• Backfill: respond to your most recent ~40–50 reviews so the profile visibly shows an engaged owner, prioritizing every unanswered negative and every detailed positive.
• Assign one owner and a backup; build it into a daily 10-minute habit, not a someday project.

Priority 2 — Defuse the pricing-transparency friction (weeks 2–8)

• This is your dominant complaint and your biggest reputational upside. Publish clear starting prices or price ranges where patients see them; train front-desk and providers to quote-then-confirm with no surprise add-ons at checkout.
• In responses to "upsell-y" reviews, calmly restate your transparent-pricing commitment (without disputing the individual's experience).
• Track whether the pricing theme fades in new reviews over the next two quarters — it is your clearest sentiment KPI.

Priority 3 — Calibrate claims (coordinate with Compliance, weeks 1–12)

• Align marketing claims with what you can substantiate. This simultaneously lifts the "inconsistent results" friction, lowers crisis vulnerability, and addresses the existential FDA/FTC exposure flagged as the audit's biggest finding. Execution detail lives in the Compliance chapter; the reputation benefit is real and immediate.

Priority 4 — Launch the compliant review-generation engine (weeks 3–12, ongoing)

• Ask everyone, every time. Post-visit, a friendly request via the channel the patient prefers (text/email), with a one-tap link. No incentives. No gating.
• Route by segment: local aesthetics patients → Google + RealSelf; hormone/longevity patients → Google + Healthgrades; international patients → Google + a Spanish-language ask.
• Make it effortless: QR codes at checkout, a link in post-visit follow-ups, staff trained to mention it warmly at the moment of delight ("if today went well, it would mean a lot…").
• Time the ask to the moment of peak satisfaction (after visible results, not before).
• Keep it HIPAA-clean: the ask references the visit generically, never clinical detail.

Priority 5 — Fill the platform gaps (weeks 4–16)

• Claim, complete, and lightly maintain RealSelf (aesthetics), Healthgrades/RateMDs (physician authority), Yelp and BBB (trust checkpoints), and a Spanish-language presence for the medical-tourism segment.
• Each filled profile is a new front door and a new shock-absorber against single-platform concentration risk.

Priority 6 — Install listening & crisis-readiness (weeks 4–8)

• Set up monitoring/alerts across Google, social comments, and Reddit/forums so you hear friction — and any adverse-event mention — first.
• Draft a one-page crisis-response protocol (who decides, who replies, HIPAA guardrails, escalation path) before you ever need it.

What "good" looks like in two quarters

A reputation profile with answered reviews top to bottom, a rising count of recent and specific 5-stars, a visibly fading pricing complaint, a presence on the aesthetics- and physician-specific platforms your best prospects actually search, claims you can stand behind, and a quiet monitoring layer so nothing blindsides you. None of that requires more ad spend. It requires management — which is exactly the gap this chapter found.

Methodology: composite reputation assessment across Google Business Profile, social, healthcare-vertical platforms (Healthgrades, RateMDs, RealSelf), medical-tourism aggregators, and back-channel forums; sentiment and theme extraction from the review corpus; owner-response and competitive benchmarking against illustrative composite competitors; crisis-vulnerability and review-generation-gap analysis. Figures are realistic composites and industry benchmarks for illustration, not guaranteed outcomes; compliance content is a marketing read, not legal advice.